Novartis To Launch Bayer MS Therapy In 2009 To Build Market Presence
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with Bayer Schering aims to bolster Novartis’ presence ahead of a potential launch of FTY720, an oral multiple sclerosis treatment.